Open Nav

Matthew Scholz



Matthew is Chief Executive Officer and co-founder of OncoSenX, a biotech firm commercializing a breakthrough technology for killing cancerous based on their genetics. A serial entrepreneur with a background in computer security, immunology and gene therapy. Matthew was previously the founder and CEO of Immusoft, a biotech firm developing a technology that turns patients’ B cells into miniature drug factories. Matthew speaks and presents regularly to university, association and scientific audiences, including those at his alma mater, the University of Washington. He served for several years as a mentor to recipients of the Thiel Fellowship, a program that awarded grants to some of the world’s brightest scientific minds under age 20.

This speaker's sessions: